Skip to content

Multicenter Trial of Meditation and Health Education for Cardiometabolic Disease in Black Women

A Clinical Trial on the Prevention of Coronary Artery Disease, Insulin Resistance and Hyperlipidemia in Black Women With Meditation and Health Education

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06443814
Enrollment
201
Registered
2024-06-05
Start date
2001-07-31
Completion date
2004-11-30
Last updated
2025-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic Cardiovascular Disease, Metabolic Syndrome

Keywords

Meditation, Transcendental Meditation, Health Education, Prevention, Health Disparities, Women's Health

Brief summary

This randomized controlled trial compared the efficacy of stress reduction with meditation to a health education (HE) group in 201 older African American women over a one-year study period. They were randomly allocated to either of two behavioral treatment groups-the Transcendental Meditation (TM) program or a health education (HE) program. Participants were recruited, tested, and instructed at two clinical sites: Howard University Hospital, Washington, DC and Morehouse (School of Medicine) Healthcare, Atlanta, GA. Main outcome measures were carotid intima-media thickness, insulin resistance, and behavioral factors.

Detailed description

This was a randomized controlled trial that compared the effects of stress reduction using the Transcendental Meditation technique (TM) to a health education (HE) group in 201 African American women \>55 years with CVD or at high CVD risk over a one-year intervention and follow-up period. All participants were randomly allocated to either of two behavioral treatment groups-1) the Transcendental Meditation (TM) program or 2) a health education (HE) program of healthy diet, exercise and substance use control. Women participants were recruited, tested, and instructed at two sites:139 were recruited and randomized in Washington, DC and 61 in Atlanta, GA. Outcome measures were carotid intima-media thickness (IMT), insulin resistance, serum lipids, blood pressure and lifestyle (diet, exercise, substance use).

Interventions

BEHAVIORALHealth Education

This was a didactic classroom-based control which educates the patient on adapting a healthier lifestyle through proper diet, exercise, and moderating substance usage according to current AHA guidelines. This intervention does not include a stress management component.

TM was taught in a standardized and validated format as a simple, natural mental technique practiced for 20 minutes twice a day (morning and evening) to give rest and relaxation to mind and body. TM was taught by a certified instructor and a 7-step process taking place over 4 consecutive days after which the meditator can practice at home twice a day.

Sponsors

Morehouse School of Medicine
CollaboratorOTHER
Howard University
CollaboratorOTHER
Robert Schneider, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Masking description

Investigators, data collectors and usual medical providers were blinded to participant treatment status. Participants in both intervention groups were given similar expectations of positive outcomes.

Intervention model description

This was a phase 2 randomized controlled trial of two behavioral interventions-Meditation and Health Education.

Eligibility

Sex/Gender
FEMALE
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* African American women, * 55 years or older with at least one of the five cardiovascular conditions (below): Either/or: * coronary heart disease or * positive coronary angiography or * previous MI or * coronary revascularization or * percutaneous transluminal coronary angioplasty (PTCA). OR a risk factor assessment score of at least two points based on the Framingham study/ATP III report. Risk factors included diabetes, high systolic or diastolic BP, high cholesterol, high LDL-low HDL or smoking.

Exclusion criteria

Recent (last 3 months): * myocardial infarction * unstable angina * coronary artery by-pass grafting (CABG) * percutaneous transluminal coronary angioplasty (PTCA) * stroke within the preceding three months * carotid artery endarterectomy * atrial fibrillation * second or third degree AV block * heart failure * clinically significant valvular heart disease * major psychiatric disorders, * current alcohol/dependency disorder * other drug abuse dependency disorder * non-cardiac life-threatening illness * participating in a formal stress management program * plans to move out of the study area or travel extensively * unwillingness to accept randomization into any study group.

Design outcomes

Primary

MeasureTime frameDescription
Carotid intima-media thickness (CIMT)0 and 12 monthsB mode ultrasound measurement of carotid artery wall thickness

Secondary

MeasureTime frameDescription
Hemoglobin A1cBefore and after 12 months of intervention and follow upHb1c as surrogate endpoint for diabetes
Insulin resistance0 and 12 monthsHOMA index utilizing glucose and insulin levels at timed intervals
Lipids0 and 12 monthsfasting levels of serum LDL, HDL, TC, TG
Blood pressure0, 4 and 12 monthsmeasured three times with a mercury sphygmomanometer 5 minutes apart and last two reading averaged
Physical Activity0, 4 and 12 monthsExercise --using the Folsom Physical Activity Questionaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026